PEDICULOSIS Clinical Trial
— ESPXOfficial title:
Phase 3 Efficacy and Safety Study for PIOLIN® Shampoo to Treat Pediculosis
This study aims to demonstrate the therapeutic efficacy and safety of Shampoo PIOLIN ® in
the treatment of human pediculosis. Will be treated 212 patients aged 2-60 years with the
infestation, along with the people in your family life. All will be submitted to the dosing
regimen recommended in the package insert. 100% of the sample shall be subjected to clinical
evaluation through comb, pre and post treatment and monitored after thirty days for
evaluation of safety and possible adverse effects that may arise related to any of the
components of the formula.
The efficacy study is active comparator, non-inferiority.
Status | Not yet recruiting |
Enrollment | 212 |
Est. completion date | October 2014 |
Est. primary completion date | September 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 2 Years to 60 Years |
Eligibility |
Inclusion Criteria: - Volunteers healthy female and male ; - Children between 2 and 17 years ; - Increased from 18 years; - Availability of volunteer to maintain a stable weight during the study period (ranging from less than 2 kg) ; - Displays lice infestation on clinical examination ; - Voluntary participation ; - Signing the consent form and / or Free and Informed Consent ; - Willingness to comply with study procedures ; - Complying that researchers can make use of all the information nameless , including publication and comply with the use and storage of all information confidential . Exclusion Criteria: - Use paint or other chemicals on the hair in the last four weeks that precede the study ; - Concomitant Therapy ; - Women who are pregnant or intend to become pregnant during the study ; - Infants ; - Volunteers not willing to sign and adhere to the Statement of Consent ; - Known hypersensitivity to the product ; - Participation in any other clinical study ; - Any other condition that the investigator decides that might interfere with the results or involving a risk to the volunteer study |
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Brazil | Ubs Fatima | Pelotas | RS |
Lead Sponsor | Collaborator |
---|---|
Phytopharm Consulting Brazil | Laboratório Saúde Ltda - principal e único patrocinador |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | EFFICACY | AFTER 17 DAYS OF TREATMENT PATIENTS SHOULD HAVE NO INFESTATION - clinically | 17 DAYS | No |
Secondary | SAFETY | IN THE END OF 30 DAYS TREATMENT PATIENTS WILL BE EVALUATED WITH BLOOD/URINE ANALYSIS FOR CHECKING ANY CHANGE - biochemistry, lab exams | 30 DAYS | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01660321 -
Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation
|
Phase 4 | |
Completed |
NCT00752973 -
Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice
|
Phase 2/Phase 3 | |
Completed |
NCT00545753 -
Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice
|
Phase 3 | |
Completed |
NCT00381082 -
A Randomised, Assessor-Blind, Comparative Efficacy Clinical Trial of 3 Pediculicides.
|
Phase 2/Phase 3 | |
Terminated |
NCT02499549 -
Two Treatment Regimens of Cocamide DEA Lotion for Head Lice
|
Phase 2/Phase 3 | |
Completed |
NCT05643820 -
Comparison of Oral Ivermectin and Permethrin 5% Lotion in Treatment of Pediculosis Capitis
|
Phase 1 | |
Completed |
NCT00731718 -
Control of Head Lice Infestations in Children and Adults
|
N/A | |
Completed |
NCT00927407 -
Pharmacokinetics of Malathion Gel 0.5% and Malathion 0.5% Lotion (Ovide) in Patients With Head Lice
|
Phase 1 | |
Completed |
NCT01518699 -
Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00207753 -
Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm Infections
|
N/A | |
Completed |
NCT00963508 -
Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice
|
Phase 3 | |
Completed |
NCT00927472 -
Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice
|
Phase 3 | |
Completed |
NCT01336647 -
An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation
|
Phase 2 |